share_log

Canaccord Genuity Reiterates Buy on Akoya Biosciences, Maintains $10 Price Target

Moomoo 24/7 ·  Mar 5 08:58

Canaccord Genuity analyst Kyle Mikson reiterates Akoya Biosciences (NASDAQ:AKYA) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment